nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—CHRM3—ureter—prostate cancer	0.171	0.681	CbGeAlD
Methacholine—Throat irritation—Estramustine—prostate cancer	0.0379	0.0609	CcSEcCtD
Methacholine—CHRM2—prostate gland—prostate cancer	0.0245	0.0975	CbGeAlD
Methacholine—Chest discomfort—Abiraterone—prostate cancer	0.021	0.0337	CcSEcCtD
Methacholine—CHRM3—prostate gland—prostate cancer	0.0199	0.0794	CbGeAlD
Methacholine—CHRM3—renal system—prostate cancer	0.0136	0.0541	CbGeAlD
Methacholine—CHRM3—urethra—prostate cancer	0.0133	0.0532	CbGeAlD
Methacholine—Cardiac arrest—Estramustine—prostate cancer	0.0132	0.0212	CcSEcCtD
Methacholine—Cardiac arrest—Cabazitaxel—prostate cancer	0.00987	0.0158	CcSEcCtD
Methacholine—Chest tightness—Docetaxel—prostate cancer	0.00929	0.0149	CcSEcCtD
Methacholine—Chest tightness—Capecitabine—prostate cancer	0.00899	0.0144	CcSEcCtD
Methacholine—CHRM3—testis—prostate cancer	0.00878	0.035	CbGeAlD
Methacholine—Cardiac arrest—Bicalutamide—prostate cancer	0.00846	0.0136	CcSEcCtD
Methacholine—Chest discomfort—Estradiol—prostate cancer	0.00764	0.0123	CcSEcCtD
Methacholine—Lightheadedness—Conjugated Estrogens—prostate cancer	0.00756	0.0121	CcSEcCtD
Methacholine—Retrosternal pain—Epirubicin—prostate cancer	0.00729	0.0117	CcSEcCtD
Methacholine—Chest pain—Estramustine—prostate cancer	0.00713	0.0114	CcSEcCtD
Methacholine—Cough—Abiraterone—prostate cancer	0.00709	0.0114	CcSEcCtD
Methacholine—Chest pain—Abiraterone—prostate cancer	0.00692	0.0111	CcSEcCtD
Methacholine—Retrosternal pain—Doxorubicin—prostate cancer	0.00675	0.0108	CcSEcCtD
Methacholine—Syncope—Nilutamide—prostate cancer	0.00666	0.0107	CcSEcCtD
Methacholine—Respiratory distress—Capecitabine—prostate cancer	0.00664	0.0107	CcSEcCtD
Methacholine—Loss of consciousness—Nilutamide—prostate cancer	0.00653	0.0105	CcSEcCtD
Methacholine—Cough—Nilutamide—prostate cancer	0.00648	0.0104	CcSEcCtD
Methacholine—Chest pain—Nilutamide—prostate cancer	0.00632	0.0101	CcSEcCtD
Methacholine—Bradycardia—Bicalutamide—prostate cancer	0.00627	0.0101	CcSEcCtD
Methacholine—Shock—Nilutamide—prostate cancer	0.00596	0.00957	CcSEcCtD
Methacholine—Chest discomfort—Etoposide—prostate cancer	0.00592	0.00951	CcSEcCtD
Methacholine—Cough—Cabazitaxel—prostate cancer	0.00545	0.00875	CcSEcCtD
Methacholine—Chest pain—Cabazitaxel—prostate cancer	0.00532	0.00854	CcSEcCtD
Methacholine—Bronchospasm—Conjugated Estrogens—prostate cancer	0.00521	0.00837	CcSEcCtD
Methacholine—Hypotension—Degarelix—prostate cancer	0.00506	0.00812	CcSEcCtD
Methacholine—Chest discomfort—Docetaxel—prostate cancer	0.00492	0.0079	CcSEcCtD
Methacholine—Pruritus—Estramustine—prostate cancer	0.00483	0.00775	CcSEcCtD
Methacholine—Syncope—Bicalutamide—prostate cancer	0.00481	0.00771	CcSEcCtD
Methacholine—Chest discomfort—Capecitabine—prostate cancer	0.00477	0.00765	CcSEcCtD
Methacholine—Hypotension—Cabazitaxel—prostate cancer	0.00477	0.00765	CcSEcCtD
Methacholine—Loss of consciousness—Bicalutamide—prostate cancer	0.00471	0.00756	CcSEcCtD
Methacholine—Cough—Bicalutamide—prostate cancer	0.00468	0.00751	CcSEcCtD
Methacholine—Pruritus—Estrone—prostate cancer	0.00462	0.00741	CcSEcCtD
Methacholine—Chest pain—Bicalutamide—prostate cancer	0.00456	0.00732	CcSEcCtD
Methacholine—L-Carnitine—MPO—prostate cancer	0.00456	1	CrCbGaD
Methacholine—Vomiting—Estramustine—prostate cancer	0.00434	0.00697	CcSEcCtD
Methacholine—Dizziness—Estrone—prostate cancer	0.00431	0.00692	CcSEcCtD
Methacholine—Shock—Bicalutamide—prostate cancer	0.0043	0.00691	CcSEcCtD
Methacholine—Pruritus—Nilutamide—prostate cancer	0.00429	0.00688	CcSEcCtD
Methacholine—Headache—Estramustine—prostate cancer	0.00428	0.00687	CcSEcCtD
Methacholine—Pruritus—Flutamide—prostate cancer	0.00427	0.00685	CcSEcCtD
Methacholine—Vomiting—Abiraterone—prostate cancer	0.00422	0.00677	CcSEcCtD
Methacholine—Bronchospasm—Estradiol—prostate cancer	0.00417	0.0067	CcSEcCtD
Methacholine—Vomiting—Estrone—prostate cancer	0.00415	0.00666	CcSEcCtD
Methacholine—Headache—Estrone—prostate cancer	0.00409	0.00656	CcSEcCtD
Methacholine—Nausea—Estramustine—prostate cancer	0.00406	0.00651	CcSEcCtD
Methacholine—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00403	0.00647	CcSEcCtD
Methacholine—Dizziness—Nilutamide—prostate cancer	0.00401	0.00643	CcSEcCtD
Methacholine—Dizziness—Flutamide—prostate cancer	0.00399	0.0064	CcSEcCtD
Methacholine—Cough—Ethinyl Estradiol—prostate cancer	0.00395	0.00635	CcSEcCtD
Methacholine—Lightheadedness—Docetaxel—prostate cancer	0.0039	0.00625	CcSEcCtD
Methacholine—Nausea—Estrone—prostate cancer	0.00388	0.00622	CcSEcCtD
Methacholine—Vomiting—Nilutamide—prostate cancer	0.00385	0.00618	CcSEcCtD
Methacholine—Vomiting—Flutamide—prostate cancer	0.00384	0.00616	CcSEcCtD
Methacholine—Pruritus—Degarelix—prostate cancer	0.00383	0.00615	CcSEcCtD
Methacholine—Headache—Nilutamide—prostate cancer	0.0038	0.00609	CcSEcCtD
Methacholine—Headache—Flutamide—prostate cancer	0.00378	0.00607	CcSEcCtD
Methacholine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00377	0.00604	CcSEcCtD
Methacholine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00362	0.00581	CcSEcCtD
Methacholine—Cardiac arrest—Etoposide—prostate cancer	0.00362	0.00581	CcSEcCtD
Methacholine—Nausea—Nilutamide—prostate cancer	0.0036	0.00578	CcSEcCtD
Methacholine—Nausea—Flutamide—prostate cancer	0.00358	0.00575	CcSEcCtD
Methacholine—Dizziness—Degarelix—prostate cancer	0.00358	0.00575	CcSEcCtD
Methacholine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00357	0.00572	CcSEcCtD
Methacholine—Vomiting—Degarelix—prostate cancer	0.00344	0.00552	CcSEcCtD
Methacholine—Headache—Degarelix—prostate cancer	0.00339	0.00544	CcSEcCtD
Methacholine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00338	0.00543	CcSEcCtD
Methacholine—Dizziness—Cabazitaxel—prostate cancer	0.00337	0.00541	CcSEcCtD
Methacholine—Syncope—Conjugated Estrogens—prostate cancer	0.00331	0.00532	CcSEcCtD
Methacholine—Cough—Goserelin—prostate cancer	0.00325	0.00522	CcSEcCtD
Methacholine—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.00325	0.00521	CcSEcCtD
Methacholine—Vomiting—Cabazitaxel—prostate cancer	0.00324	0.0052	CcSEcCtD
Methacholine—Bronchospasm—Etoposide—prostate cancer	0.00323	0.00519	CcSEcCtD
Methacholine—Cough—Conjugated Estrogens—prostate cancer	0.00322	0.00517	CcSEcCtD
Methacholine—Bradycardia—Mitoxantrone—prostate cancer	0.00322	0.00517	CcSEcCtD
Methacholine—Nausea—Degarelix—prostate cancer	0.00322	0.00516	CcSEcCtD
Methacholine—Headache—Cabazitaxel—prostate cancer	0.00319	0.00513	CcSEcCtD
Methacholine—Chest pain—Goserelin—prostate cancer	0.00317	0.00509	CcSEcCtD
Methacholine—Chest pain—Conjugated Estrogens—prostate cancer	0.00314	0.00505	CcSEcCtD
Methacholine—Pruritus—Bicalutamide—prostate cancer	0.0031	0.00497	CcSEcCtD
Methacholine—Nausea—Cabazitaxel—prostate cancer	0.00303	0.00486	CcSEcCtD
Methacholine—Shock—Goserelin—prostate cancer	0.00299	0.0048	CcSEcCtD
Methacholine—Shock—Conjugated Estrogens—prostate cancer	0.00297	0.00476	CcSEcCtD
Methacholine—Cardiac arrest—Capecitabine—prostate cancer	0.00291	0.00467	CcSEcCtD
Methacholine—Dizziness—Bicalutamide—prostate cancer	0.00289	0.00464	CcSEcCtD
Methacholine—Hypotension—Goserelin—prostate cancer	0.00284	0.00456	CcSEcCtD
Methacholine—Hypotension—Conjugated Estrogens—prostate cancer	0.00282	0.00452	CcSEcCtD
Methacholine—Vomiting—Bicalutamide—prostate cancer	0.00278	0.00446	CcSEcCtD
Methacholine—Headache—Bicalutamide—prostate cancer	0.00274	0.0044	CcSEcCtD
Methacholine—Bronchospasm—Docetaxel—prostate cancer	0.00269	0.00431	CcSEcCtD
Methacholine—Syncope—Estradiol—prostate cancer	0.00265	0.00425	CcSEcCtD
Methacholine—Pruritus—Ethinyl Estradiol—prostate cancer	0.00262	0.0042	CcSEcCtD
Methacholine—Bronchospasm—Capecitabine—prostate cancer	0.0026	0.00418	CcSEcCtD
Methacholine—Nausea—Bicalutamide—prostate cancer	0.0026	0.00417	CcSEcCtD
Methacholine—Loss of consciousness—Estradiol—prostate cancer	0.0026	0.00417	CcSEcCtD
Methacholine—Cardiac arrest—Prednisone—prostate cancer	0.00259	0.00416	CcSEcCtD
Methacholine—Cough—Estradiol—prostate cancer	0.00258	0.00414	CcSEcCtD
Methacholine—Chest pain—Estradiol—prostate cancer	0.00252	0.00404	CcSEcCtD
Methacholine—Dizziness—Ethinyl Estradiol—prostate cancer	0.00245	0.00392	CcSEcCtD
Methacholine—Cough—Mitoxantrone—prostate cancer	0.0024	0.00386	CcSEcCtD
Methacholine—Shock—Estradiol—prostate cancer	0.00237	0.00381	CcSEcCtD
Methacholine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00235	0.00377	CcSEcCtD
Methacholine—Chest pain—Mitoxantrone—prostate cancer	0.00235	0.00376	CcSEcCtD
Methacholine—Headache—Ethinyl Estradiol—prostate cancer	0.00232	0.00372	CcSEcCtD
Methacholine—Shock—Mitoxantrone—prostate cancer	0.00221	0.00355	CcSEcCtD
Methacholine—Nausea—Ethinyl Estradiol—prostate cancer	0.0022	0.00352	CcSEcCtD
Methacholine—Bradycardia—Capecitabine—prostate cancer	0.00216	0.00346	CcSEcCtD
Methacholine—Pruritus—Goserelin—prostate cancer	0.00215	0.00346	CcSEcCtD
Methacholine—Pruritus—Conjugated Estrogens—prostate cancer	0.00213	0.00342	CcSEcCtD
Methacholine—Hypotension—Mitoxantrone—prostate cancer	0.0021	0.00337	CcSEcCtD
Methacholine—Cardiac arrest—Epirubicin—prostate cancer	0.00203	0.00325	CcSEcCtD
Methacholine—Loss of consciousness—Etoposide—prostate cancer	0.00201	0.00323	CcSEcCtD
Methacholine—Dizziness—Goserelin—prostate cancer	0.00201	0.00323	CcSEcCtD
Methacholine—Cough—Etoposide—prostate cancer	0.002	0.00321	CcSEcCtD
Methacholine—Dizziness—Conjugated Estrogens—prostate cancer	0.00199	0.0032	CcSEcCtD
Methacholine—Chest pain—Etoposide—prostate cancer	0.00195	0.00313	CcSEcCtD
Methacholine—Vomiting—Goserelin—prostate cancer	0.00194	0.00311	CcSEcCtD
Methacholine—Bradycardia—Prednisone—prostate cancer	0.00192	0.00308	CcSEcCtD
Methacholine—Vomiting—Conjugated Estrogens—prostate cancer	0.00192	0.00308	CcSEcCtD
Methacholine—Headache—Goserelin—prostate cancer	0.00191	0.00306	CcSEcCtD
Methacholine—Headache—Conjugated Estrogens—prostate cancer	0.00189	0.00303	CcSEcCtD
Methacholine—Cardiac arrest—Doxorubicin—prostate cancer	0.00188	0.00301	CcSEcCtD
Methacholine—Nausea—Goserelin—prostate cancer	0.00181	0.0029	CcSEcCtD
Methacholine—Nausea—Conjugated Estrogens—prostate cancer	0.00179	0.00287	CcSEcCtD
Methacholine—Hypotension—Etoposide—prostate cancer	0.00175	0.0028	CcSEcCtD
Methacholine—Syncope—Docetaxel—prostate cancer	0.00171	0.00274	CcSEcCtD
Methacholine—Pruritus—Estradiol—prostate cancer	0.00171	0.00274	CcSEcCtD
Methacholine—Loss of consciousness—Docetaxel—prostate cancer	0.00167	0.00269	CcSEcCtD
Methacholine—Cough—Docetaxel—prostate cancer	0.00166	0.00267	CcSEcCtD
Methacholine—Syncope—Capecitabine—prostate cancer	0.00165	0.00265	CcSEcCtD
Methacholine—Chest pain—Docetaxel—prostate cancer	0.00162	0.0026	CcSEcCtD
Methacholine—Loss of consciousness—Capecitabine—prostate cancer	0.00162	0.0026	CcSEcCtD
Methacholine—Cough—Capecitabine—prostate cancer	0.00161	0.00258	CcSEcCtD
Methacholine—Dizziness—Estradiol—prostate cancer	0.0016	0.00256	CcSEcCtD
Methacholine—Chest pain—Capecitabine—prostate cancer	0.00157	0.00252	CcSEcCtD
Methacholine—Vomiting—Estradiol—prostate cancer	0.00153	0.00246	CcSEcCtD
Methacholine—Shock—Docetaxel—prostate cancer	0.00153	0.00245	CcSEcCtD
Methacholine—Headache—Estradiol—prostate cancer	0.00151	0.00243	CcSEcCtD
Methacholine—Bradycardia—Epirubicin—prostate cancer	0.0015	0.00241	CcSEcCtD
Methacholine—Shock—Capecitabine—prostate cancer	0.00148	0.00238	CcSEcCtD
Methacholine—Syncope—Prednisone—prostate cancer	0.00147	0.00236	CcSEcCtD
Methacholine—Hypotension—Docetaxel—prostate cancer	0.00145	0.00233	CcSEcCtD
Methacholine—Loss of consciousness—Prednisone—prostate cancer	0.00144	0.00232	CcSEcCtD
Methacholine—Nausea—Estradiol—prostate cancer	0.00143	0.0023	CcSEcCtD
Methacholine—Vomiting—Mitoxantrone—prostate cancer	0.00143	0.00229	CcSEcCtD
Methacholine—Headache—Mitoxantrone—prostate cancer	0.00141	0.00226	CcSEcCtD
Methacholine—Hypotension—Capecitabine—prostate cancer	0.00141	0.00226	CcSEcCtD
Methacholine—Bradycardia—Doxorubicin—prostate cancer	0.00139	0.00223	CcSEcCtD
Methacholine—Nausea—Mitoxantrone—prostate cancer	0.00134	0.00214	CcSEcCtD
Methacholine—Pruritus—Etoposide—prostate cancer	0.00132	0.00212	CcSEcCtD
Methacholine—Shock—Prednisone—prostate cancer	0.00132	0.00212	CcSEcCtD
Methacholine—Dizziness—Etoposide—prostate cancer	0.00124	0.00198	CcSEcCtD
Methacholine—Vomiting—Etoposide—prostate cancer	0.00119	0.00191	CcSEcCtD
Methacholine—Headache—Etoposide—prostate cancer	0.00117	0.00188	CcSEcCtD
Methacholine—Syncope—Epirubicin—prostate cancer	0.00115	0.00185	CcSEcCtD
Methacholine—Loss of consciousness—Epirubicin—prostate cancer	0.00113	0.00181	CcSEcCtD
Methacholine—Cough—Epirubicin—prostate cancer	0.00112	0.0018	CcSEcCtD
Methacholine—Nausea—Etoposide—prostate cancer	0.00111	0.00178	CcSEcCtD
Methacholine—Pruritus—Docetaxel—prostate cancer	0.0011	0.00176	CcSEcCtD
Methacholine—Chest pain—Epirubicin—prostate cancer	0.00109	0.00175	CcSEcCtD
Methacholine—Syncope—Doxorubicin—prostate cancer	0.00107	0.00171	CcSEcCtD
Methacholine—Pruritus—Capecitabine—prostate cancer	0.00106	0.00171	CcSEcCtD
Methacholine—Loss of consciousness—Doxorubicin—prostate cancer	0.00104	0.00168	CcSEcCtD
Methacholine—Cough—Doxorubicin—prostate cancer	0.00104	0.00166	CcSEcCtD
Methacholine—Shock—Epirubicin—prostate cancer	0.00103	0.00165	CcSEcCtD
Methacholine—Dizziness—Docetaxel—prostate cancer	0.00103	0.00165	CcSEcCtD
Methacholine—Chest pain—Doxorubicin—prostate cancer	0.00101	0.00162	CcSEcCtD
Methacholine—Dizziness—Capecitabine—prostate cancer	0.000995	0.0016	CcSEcCtD
Methacholine—Vomiting—Docetaxel—prostate cancer	0.000988	0.00159	CcSEcCtD
Methacholine—Hypotension—Epirubicin—prostate cancer	0.000979	0.00157	CcSEcCtD
Methacholine—Headache—Docetaxel—prostate cancer	0.000974	0.00156	CcSEcCtD
Methacholine—Vomiting—Capecitabine—prostate cancer	0.000957	0.00154	CcSEcCtD
Methacholine—Shock—Doxorubicin—prostate cancer	0.000954	0.00153	CcSEcCtD
Methacholine—Pruritus—Prednisone—prostate cancer	0.000948	0.00152	CcSEcCtD
Methacholine—Headache—Capecitabine—prostate cancer	0.000943	0.00151	CcSEcCtD
Methacholine—Nausea—Docetaxel—prostate cancer	0.000923	0.00148	CcSEcCtD
Methacholine—Hypotension—Doxorubicin—prostate cancer	0.000906	0.00145	CcSEcCtD
Methacholine—Nausea—Capecitabine—prostate cancer	0.000894	0.00143	CcSEcCtD
Methacholine—Dizziness—Prednisone—prostate cancer	0.000886	0.00142	CcSEcCtD
Methacholine—Vomiting—Prednisone—prostate cancer	0.000852	0.00137	CcSEcCtD
Methacholine—Headache—Prednisone—prostate cancer	0.00084	0.00135	CcSEcCtD
Methacholine—Nausea—Prednisone—prostate cancer	0.000796	0.00128	CcSEcCtD
Methacholine—Pruritus—Epirubicin—prostate cancer	0.000742	0.00119	CcSEcCtD
Methacholine—Dizziness—Epirubicin—prostate cancer	0.000693	0.00111	CcSEcCtD
Methacholine—Pruritus—Doxorubicin—prostate cancer	0.000686	0.0011	CcSEcCtD
Methacholine—Vomiting—Epirubicin—prostate cancer	0.000666	0.00107	CcSEcCtD
Methacholine—Headache—Epirubicin—prostate cancer	0.000657	0.00105	CcSEcCtD
Methacholine—Dizziness—Doxorubicin—prostate cancer	0.000641	0.00103	CcSEcCtD
Methacholine—Nausea—Epirubicin—prostate cancer	0.000623	0.000999	CcSEcCtD
Methacholine—Vomiting—Doxorubicin—prostate cancer	0.000617	0.00099	CcSEcCtD
Methacholine—Headache—Doxorubicin—prostate cancer	0.000608	0.000975	CcSEcCtD
Methacholine—Nausea—Doxorubicin—prostate cancer	0.000576	0.000924	CcSEcCtD
Methacholine—CHRM3—Metabolism—HPGDS—prostate cancer	7.84e-05	0.000646	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP2C19—prostate cancer	7.79e-05	0.000642	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLCB2—prostate cancer	7.79e-05	0.000642	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LRP2—prostate cancer	7.79e-05	0.000642	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRB2—prostate cancer	7.76e-05	0.00064	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CX3CL1—prostate cancer	7.71e-05	0.000635	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—P4HB—prostate cancer	7.71e-05	0.000635	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	7.69e-05	0.000633	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—P4HB—prostate cancer	7.64e-05	0.000629	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	7.64e-05	0.000629	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ACHE—prostate cancer	7.61e-05	0.000627	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTT1—prostate cancer	7.61e-05	0.000627	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—VAV3—prostate cancer	7.57e-05	0.000624	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIST1H2BG—prostate cancer	7.57e-05	0.000624	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP2A6—prostate cancer	7.52e-05	0.000619	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GRB7—prostate cancer	7.5e-05	0.000618	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDE4D—prostate cancer	7.5e-05	0.000618	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—VAV3—prostate cancer	7.5e-05	0.000618	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	7.5e-05	0.000618	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDE4D—prostate cancer	7.43e-05	0.000612	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GRB7—prostate cancer	7.43e-05	0.000612	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ITPR1—prostate cancer	7.34e-05	0.000605	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKR1C3—prostate cancer	7.31e-05	0.000603	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIST1H4H—prostate cancer	7.31e-05	0.000602	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—CXCL8—prostate cancer	7.31e-05	0.000602	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	7.28e-05	0.0006	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PRKACB—prostate cancer	7.27e-05	0.000599	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	7.27e-05	0.000599	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	7.24e-05	0.000596	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	7.24e-05	0.000596	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP17A1—prostate cancer	7.2e-05	0.000593	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GNG5—prostate cancer	7.14e-05	0.000588	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GNG5—prostate cancer	7.07e-05	0.000582	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NCOA2—prostate cancer	6.86e-05	0.000565	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC5A5—prostate cancer	6.54e-05	0.000539	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP2E1—prostate cancer	6.39e-05	0.000527	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NQO1—prostate cancer	6.32e-05	0.000521	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TH—prostate cancer	6.23e-05	0.000513	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFBR1—prostate cancer	6.22e-05	0.000512	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTHLH—prostate cancer	6.22e-05	0.000512	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP3A4—prostate cancer	6.16e-05	0.000508	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTHLH—prostate cancer	6.16e-05	0.000507	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	6.16e-05	0.000507	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKR1C3—prostate cancer	6.12e-05	0.000504	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKACB—prostate cancer	6.08e-05	0.000501	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP1B1—prostate cancer	6.06e-05	0.000499	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	6.06e-05	0.000499	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKACB—prostate cancer	6.02e-05	0.000496	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—THBS1—prostate cancer	5.93e-05	0.000489	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PPP3CA—prostate cancer	5.93e-05	0.000489	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	5.87e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—THBS1—prostate cancer	5.87e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GGT1—prostate cancer	5.87e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ANXA1—prostate cancer	5.84e-05	0.000481	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ANXA1—prostate cancer	5.79e-05	0.000477	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NCOA1—prostate cancer	5.78e-05	0.000476	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCZ—prostate cancer	5.74e-05	0.000473	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP19A1—prostate cancer	5.7e-05	0.000469	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	5.68e-05	0.000468	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CG—prostate cancer	5.61e-05	0.000462	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	5.55e-05	0.000457	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGFR4—prostate cancer	5.54e-05	0.000456	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PARP1—prostate cancer	5.54e-05	0.000456	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—RXRA—prostate cancer	5.5e-05	0.000453	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGFR4—prostate cancer	5.49e-05	0.000452	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PARP1—prostate cancer	5.49e-05	0.000452	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CALCA—prostate cancer	5.47e-05	0.000451	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CALCA—prostate cancer	5.42e-05	0.000446	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL12—prostate cancer	5.35e-05	0.00044	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—COMT—prostate cancer	5.3e-05	0.000436	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL12—prostate cancer	5.29e-05	0.000436	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTP1—prostate cancer	5.27e-05	0.000434	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ITPR1—prostate cancer	5.19e-05	0.000427	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CG—prostate cancer	5.09e-05	0.00042	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	5.04e-05	0.000415	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP9—prostate cancer	5.03e-05	0.000415	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP9—prostate cancer	4.98e-05	0.000411	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CD—prostate cancer	4.93e-05	0.000406	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TYMS—prostate cancer	4.9e-05	0.000404	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	4.88e-05	0.000402	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NGFR—prostate cancer	4.88e-05	0.000402	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCQ—prostate cancer	4.88e-05	0.000402	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—prostate cancer	4.84e-05	0.000399	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	4.83e-05	0.000398	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NGFR—prostate cancer	4.83e-05	0.000398	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAP3K7—prostate cancer	4.82e-05	0.000397	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	4.77e-05	0.000393	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LPL—prostate cancer	4.76e-05	0.000392	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF10—prostate cancer	4.63e-05	0.000382	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP1A1—prostate cancer	4.59e-05	0.000378	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF10—prostate cancer	4.59e-05	0.000378	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRB2—prostate cancer	4.59e-05	0.000378	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ERCC2—prostate cancer	4.55e-05	0.000375	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRB2—prostate cancer	4.54e-05	0.000374	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—JAK2—prostate cancer	4.52e-05	0.000373	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MAP2K1—prostate cancer	4.51e-05	0.000371	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	4.48e-05	0.000369	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CD—prostate cancer	4.48e-05	0.000369	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VAV3—prostate cancer	4.47e-05	0.000368	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	4.46e-05	0.000368	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	4.43e-05	0.000365	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VAV3—prostate cancer	4.43e-05	0.000365	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	4.41e-05	0.000363	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	4.37e-05	0.00036	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ITPR1—prostate cancer	4.34e-05	0.000357	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	4.3e-05	0.000354	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ITPR1—prostate cancer	4.3e-05	0.000354	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—prostate cancer	4.28e-05	0.000353	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	4.25e-05	0.000351	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARA—prostate cancer	4.2e-05	0.000346	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1R—prostate cancer	4.15e-05	0.000342	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	4.13e-05	0.00034	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—JAK2—prostate cancer	4.11e-05	0.000338	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1R—prostate cancer	4.11e-05	0.000338	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	4.09e-05	0.000337	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—JAK2—prostate cancer	4.07e-05	0.000335	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LPL—prostate cancer	3.98e-05	0.000328	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CAV1—prostate cancer	3.95e-05	0.000325	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—IL2—prostate cancer	3.95e-05	0.000325	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	3.94e-05	0.000325	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LPL—prostate cancer	3.94e-05	0.000324	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—IL2—prostate cancer	3.91e-05	0.000322	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	3.9e-05	0.000322	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	3.9e-05	0.000321	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	3.86e-05	0.000318	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ITGB3—prostate cancer	3.84e-05	0.000316	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ITGB3—prostate cancer	3.8e-05	0.000313	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	3.75e-05	0.000309	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ERBB3—prostate cancer	3.72e-05	0.000307	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGFR2—prostate cancer	3.72e-05	0.000306	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	3.71e-05	0.000306	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ERBB3—prostate cancer	3.69e-05	0.000304	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGFR2—prostate cancer	3.68e-05	0.000303	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CG—prostate cancer	3.6e-05	0.000296	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL2—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TERT—prostate cancer	3.57e-05	0.000294	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL2—prostate cancer	3.55e-05	0.000292	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TERT—prostate cancer	3.54e-05	0.000291	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIF1A—prostate cancer	3.41e-05	0.000281	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—INS—prostate cancer	3.41e-05	0.000281	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	3.38e-05	0.000279	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CREBBP—prostate cancer	3.34e-05	0.000275	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LEP—prostate cancer	3.33e-05	0.000275	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CAV1—prostate cancer	3.3e-05	0.000272	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LEP—prostate cancer	3.3e-05	0.000272	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CAV1—prostate cancer	3.27e-05	0.000269	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KDR—prostate cancer	3.27e-05	0.000269	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KDR—prostate cancer	3.23e-05	0.000266	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ESR1—prostate cancer	3.18e-05	0.000262	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CD—prostate cancer	3.16e-05	0.000261	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ESR1—prostate cancer	3.15e-05	0.00026	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—BAD—prostate cancer	3.11e-05	0.000256	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—BAD—prostate cancer	3.08e-05	0.000253	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	3.01e-05	0.000248	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APC—prostate cancer	3.01e-05	0.000248	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NOS3—prostate cancer	2.99e-05	0.000246	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APC—prostate cancer	2.98e-05	0.000245	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	2.98e-05	0.000245	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGF—prostate cancer	2.97e-05	0.000245	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IRS1—prostate cancer	2.97e-05	0.000245	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGF—prostate cancer	2.94e-05	0.000243	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IRS1—prostate cancer	2.94e-05	0.000243	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GSK3B—prostate cancer	2.89e-05	0.000238	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	2.86e-05	0.000235	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INS—prostate cancer	2.85e-05	0.000235	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INS—prostate cancer	2.82e-05	0.000232	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CREBBP—prostate cancer	2.79e-05	0.00023	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	2.76e-05	0.000228	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CB—prostate cancer	2.76e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1—prostate cancer	2.75e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EGFR—prostate cancer	2.74e-05	0.000226	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTGS2—prostate cancer	2.73e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1—prostate cancer	2.73e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	2.71e-05	0.000224	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	2.66e-05	0.000219	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	2.64e-05	0.000218	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	2.64e-05	0.000217	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	2.62e-05	0.000216	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	2.62e-05	0.000216	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	2.62e-05	0.000215	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	2.59e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	2.59e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—KRAS—prostate cancer	2.59e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	2.56e-05	0.000211	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF2—prostate cancer	2.53e-05	0.000209	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF2—prostate cancer	2.51e-05	0.000207	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOS3—prostate cancer	2.5e-05	0.000206	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOS3—prostate cancer	2.47e-05	0.000204	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAK2—prostate cancer	2.43e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAK2—prostate cancer	2.4e-05	0.000198	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTEN—prostate cancer	2.38e-05	0.000196	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	2.38e-05	0.000196	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MDM2—prostate cancer	2.37e-05	0.000195	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	2.36e-05	0.000194	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MDM2—prostate cancer	2.35e-05	0.000193	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ERBB2—prostate cancer	2.34e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	2.31e-05	0.000191	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	2.3e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	2.28e-05	0.000188	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—EP300—prostate cancer	2.27e-05	0.000187	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL8—prostate cancer	2.21e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	2.19e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	2.16e-05	0.000178	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	2.14e-05	0.000176	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	2.14e-05	0.000176	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—prostate cancer	2.12e-05	0.000175	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	2.12e-05	0.000175	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL2—prostate cancer	2.12e-05	0.000174	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—prostate cancer	2.11e-05	0.000174	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—prostate cancer	2.1e-05	0.000173	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL2—prostate cancer	2.1e-05	0.000173	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—prostate cancer	2.09e-05	0.000172	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCND1—prostate cancer	2.06e-05	0.00017	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	2.04e-05	0.000168	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCND1—prostate cancer	2.04e-05	0.000168	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	2.02e-05	0.000167	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP9—prostate cancer	2e-05	0.000165	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	2e-05	0.000164	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTEN—prostate cancer	1.99e-05	0.000164	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.98e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.98e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.97e-05	0.000162	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	1.94e-05	0.00016	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.92e-05	0.000159	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EP300—prostate cancer	1.9e-05	0.000156	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.88e-05	0.000155	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SRC—prostate cancer	1.85e-05	0.000152	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.83e-05	0.000151	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	1.8e-05	0.000148	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.78e-05	0.000147	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT3—prostate cancer	1.78e-05	0.000147	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.76e-05	0.000145	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CA—prostate cancer	1.68e-05	0.000138	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MYC—prostate cancer	1.66e-05	0.000136	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	1.65e-05	0.000136	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.64e-05	0.000135	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.64e-05	0.000135	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGFR—prostate cancer	1.62e-05	0.000133	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.6e-05	0.000132	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KRAS—prostate cancer	1.53e-05	0.000126	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.51e-05	0.000125	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	1.41e-05	0.000116	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.39e-05	0.000115	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—prostate cancer	1.37e-05	0.000113	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TP53—prostate cancer	1.36e-05	0.000112	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TP53—prostate cancer	1.35e-05	0.000111	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—prostate cancer	1.24e-05	0.000103	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—prostate cancer	1.23e-05	0.000102	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—prostate cancer	1.15e-05	9.46e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—prostate cancer	1.14e-05	9.36e-05	CbGpPWpGaD
